Research Paper Volume 16, Issue 8 pp 7188—7216

Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer


Figure 8. (A) Correlation analysis between TPX2 expression and representative immune checkpoints from TCGA database. (B) The relationship between TPX2 expression and immune microenvironment. *P < 0.05, **P < 0.01, ***P < 0.001.